Tzuriel Sapir
9PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 13, 2025
A Further Case for Targeting PRMT5 and the ERK1/2 and PI3K Pathways in CRC.Mark Spivak, Moshe Pahmer, Dorna Delrahimnia
|Oct 07, 2025
Risk factors associated with beta-peripapillary atrophy in individuals of African ancestry with primary open-angle glaucoma.Tzuriel Sapir, Rebecca Salowe, Yineng Chen
|Sep 13, 2025
Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer.Ethan Abizadeh, Eli Berglas, Aaron Abizadeh
|Aug 28, 2025
Current and Emerging Therapies for Targeting Protein Arginine Methyltransferases (PRMTs) in Cancer.Adriana Kaganovski, Bayle Smith-Salzberg, Hadar K Shimshon
|Aug 27, 2025
PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5-KRAS Crosstalk.Mark Spivak, Moshe Pahmer, Dorna Delrahimnia
|Jul 27, 2024
Primary Open-Angle Glaucoma Is Associated with Short-Term Memory Decline and Dementia in Individuals of African Ancestry.Tzuriel Sapir, Patrick Augello, Roy Lee
Pageof 2
